KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Repligen (RGEN) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Repligen (RGEN) over the last 16 years, with Q3 2025 value amounting to $4.7 million.

  • Repligen's Capital Expenditures fell 3266.5% to $4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.9 million, marking a year-over-year decrease of 3304.51%. This contributed to the annual value of $25.7 million for FY2024, which is 2911.21% down from last year.
  • As of Q3 2025, Repligen's Capital Expenditures stood at $4.7 million, which was down 3266.5% from $7.1 million recorded in Q2 2025.
  • In the past 5 years, Repligen's Capital Expenditures ranged from a high of $32.1 million in Q4 2021 and a low of $3.6 million during Q1 2025
  • In the last 5 years, Repligen's Capital Expenditures had a median value of $8.4 million in 2023 and averaged $12.1 million.
  • Its Capital Expenditures has fluctuated over the past 5 years, first surged by 42113.74% in 2021, then plummeted by 6872.15% in 2023.
  • Repligen's Capital Expenditures (Quarter) stood at $32.1 million in 2021, then plummeted by 36.35% to $20.4 million in 2022, then plummeted by 45.77% to $11.1 million in 2023, then plummeted by 50.03% to $5.5 million in 2024, then dropped by 15.13% to $4.7 million in 2025.
  • Its last three reported values are $4.7 million in Q3 2025, $7.1 million for Q2 2025, and $3.6 million during Q1 2025.